Adagio Therapeutics Inc. Gains 16.04%
Thu, Jan 20, 2022 at 05:35 PM
Adagio Therapeutics Inc. (ADGI:NASDAQ) rocketted at $6.44, representing a gain of 16%. The stock appeared on our News Catalysts scanner on Thu, Jan 13, 2022 at 12:37 PM in the 'MISCELLANEOUS' category. From Thu, Jan 06, 2022, the stock recorded 37.50% Up Days and 33.33% Green Days
The stock spiked on Tue, Nov 30, 2021 at $78.82 with a volume of 19M+.
About Adagio Therapeutics Inc. (ADGI:NASDAQ)
Adagio Therapeutics Inc is a clinical-stage biopharmaceutical company.
Top 10 Gainers:
- Aptorum Group Limited (APM:NASDAQ), 38.52%
- Hillstream BioPharma Inc. (HILS:NASDAQ), 21.79%
- AMTD International Inc. (HKIB:NYSE), 16.63%
- Adagio Therapeutics Inc. (ADGI:NASDAQ), 16.04%
- Amesite Inc. (AMST:NASDAQ), 15.93%
- Pintec Technology Holdings Limited (PT:NASDAQ), 15.19%
- Bragg Gaming Group Inc. (BRAG:NASDAQ), 14.65%
- Society Pass Incorporated (SOPA:NASDAQ), 12.45%
- HCW Biologics Inc. (HCWB:NASDAQ), 12.08%
- OncoCyte Corporation (OCX:NASDAQ), 12.05%